Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06071468 · ClinicalTrials.gov registry record

Registry of the Patient Experience for Carpal Tunnel Release

A clinical trial of Carpal Tunnel Syndrome and CTS, sponsored by Sonex Health.

Active
Registry status
2,000
Enrollment target
20
Study locations

NCT06071468: Active study of Carpal Tunnel Syndrome and CTS, sponsored by Sonex Health.

NCT06071468 is a study of Carpal Tunnel Syndrome and CTS that is active but no longer recruiting, run by Sonex Health. The registered enrollment target is 2,000 participants, above the 127-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (1475% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06071468, a study of Carpal Tunnel Syndrome and CTS, is active but no longer recruiting, sponsored by Sonex Health.

ACTIVE NOT RECRUITING
Registry status
2,000 participants
Enrollment target
20
Study locations

Study Summary

Multi-center study to collect large scale, multidimensional real-world data on patients undergoing carpal tunnel release (CTR).

Primary Outcome

Scoring for the BCTQ- SSS ranges from 1 to 5, with higher scores indicating more severe symptoms, and is calculated as the mean of each response. The change in BCTQ-SSS score at the 24-month follow-up relative to baseline.

Interventions

  • DEVICE UltraGuideCTR (Device) with Ultrasound Guided Carpal Tunnel Release (CTR-US)
  • PROCEDURE Endocscopic CTR
  • PROCEDURE Open CTR

Study Locations (20)

Florida

  • Aventura Hand Center (CTR-US) - Aventura
  • Orthopaedic Associates (CTR-US) - Fort Walton Beach
  • Central Florida Orthopaedic Surgery Associates, P.L (CTR-US) - Lakeland
  • Melbourne Hand Center (OCTR) - Melbourne
  • Miami Hand Center (NHVP) - Miami
  • The Orthopaedic Hand and Arm Center (CTR-US) - Miami Lakes

Massachusetts

  • Cape Cod Orthopaedics (CTR-US) - Hyannis
  • Excel Orthopaedic Specialists (CTR-US) - Woburn

New Hampshire

  • Dartmouth Hitchcock Clinic (ECTR) - Lebanon
  • Mobility Bone and Joint Institute (CTR-US) - Salem

Alabama

  • The Orthopaedic Group P.C. (CTR-US) - Foley

Arizona

  • Phoenix Hand (CTR-US) - Scottsdale

Connecticut

  • Orthopaedics Associates of Hartford (OCTR) - Glastonbury

Indiana

  • Tri-State Orthopaedics (CTR-US) - Evansville

Kentucky

  • Bluegrass Orthopaedics (CTR-US) - Lexington

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2024-01-26
Est. Completion 2027-12-31
Sonex Health

4 total trials

What the registry record for NCT06071468 still lists

NCT06071468 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 127-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (1475% higher).

The record links to 2 conditions, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 3 interventions - of which UltraGuideCTR (Device) with Ultrasound Guided Carpal Tunnel Release (CTR-US) is the first listed.

NCT06071468 names 20 study sites across 13 states, led by Florida, Massachusetts, New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06071468 about?

NCT06071468 is a clinical study titled "Registry of the Patient Experience for Carpal Tunnel Release". Multi-center study to collect large scale, multidimensional real-world data on patients undergoing carpal tunnel release (CTR).

What is the current status of trial NCT06071468?

This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2024-01-26. Estimated completion is 2027-12-31.

What conditions does trial NCT06071468 study?

This clinical trial studies the following conditions: Carpal Tunnel Syndrome, CTS.

What interventions are being tested in trial NCT06071468?

The interventions under investigation include: UltraGuideCTR (Device) with Ultrasound Guided Carpal Tunnel Release (CTR-US) (DEVICE), Endocscopic CTR (PROCEDURE), Open CTR (PROCEDURE).

Who is sponsoring clinical trial NCT06071468?

This trial is sponsored by Sonex Health, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06071468 being conducted?

This trial has 20 study locations across Alabama, Arizona, Connecticut, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carpal Tunnel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06071468's enrollment target sits among peer trials

2,000 1st of 21 higher than 21 of 21 other Carpal Tunnel Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Carpal Tunnel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06071468, the US trial registry maintained by the National Library of Medicine. NCT06071468 (large enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.